Kaleido Biosciences, Inc. (OTC:KLDO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Noubar Afeyan Other companies: Generate Biomedicines, Inc. (Chair of the Board · Since at least Feb 26, 2026); Foghorn Therapeutics Inc. (Director · Since at least Jan 13, 2026); Moderna, Inc. (Director · Since at least Dec 7, 2018); BG Medicine Inc (Director · Since at least Feb 3, 2011); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 7, 2023 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 12, 2019 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 21, 2016 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 18, 2019 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Mar 20, 2014 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Sep 25, 2013 · Past); Color Kinetics Inc (Director · Jan 3, 2006 – Aug 24, 2007 · Past); Agenus Inc. (Director · Jan 13, 2005 – Jun 7, 2007 · Past) | Director · Feb 27, 2019 – Mar 4, 2019 · Past |
| Michael W. Bonney Other companies: Immunic, Inc. (Chair · Since May 16, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Dec 17, 2014); Bristol-Myers Squibb Company (Director · Nov 20, 2019 – Jun 30, 2021 · Past); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 1, 2021 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 14, 2018 – Jun 11, 2019 · Past); Sarepta Therapeutics, Inc. (Director · Dec 4, 2017 – Feb 28, 2020 · Past); Global Blood Therapeutics Inc (Director · Feb 8, 2016 – Jun 16, 2016 · Past); Celgene Corporation (Director · Apr 14, 2015 – Nov 20, 2019 · Past); NPS Pharmaceuticals Inc (Director · Jan 17, 2006 – Feb 21, 2015 · Past); Cubist Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past) | Director · Feb 27, 2019 – Jun 30, 2021 · Past |
| Alison Frances Lawton Other companies: ProQR Therapeutics N.V. (Director · Since at least Mar 18, 2026); Dianthus Therapeutics, Inc. (Director · Since at least Dec 22, 2020); Spyre Therapeutics, Inc. (Director · Dec 15, 2020 – Jun 22, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Oct 5, 2020 – Jun 10, 2024 · Past); CoLucid Pharmaceuticals Inc (Director · Mar 11, 2016 – Mar 1, 2017 · Past); Tempest Therapeutics, Inc. (Chief Operating Officer · Jan 21, 2013 – Jun 7, 2013 · Past); Verastem, Inc. (Director · Nov 26, 2012 – Jun 21, 2019 · Past); Cubist Pharmaceuticals Inc (Director · Feb 15, 2012 – Jan 21, 2015 · Past) | See Remarks, Director · Feb 27, 2019 – Apr 15, 2020 · Past |
| Katharine Knobil Other companies: Korro Bio, Inc. (Director · Since at least Aug 26, 2024); Pliant Therapeutics, Inc. (Director · Since at least Sep 14, 2022); Marker Therapeutics, Inc. (Chief Medical Officer, Altesa BioSciences, Inc. · Since at least Dec 8, 2021); Arena Pharmaceuticals Inc (Director · Jun 12, 2020 – Mar 11, 2022 · Past) | Chief Medical Officer · Feb 27, 2019 – Oct 15, 2020 · Past |
| Kyriazi Theo Melas Other companies: Codiak BioSciences Inc (Director · Oct 13, 2020 – Feb 16, 2023 · Past); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 8, 2023 · Past); Bausch Health Companies Inc. (Director · Sep 28, 2010 – May 2, 2016 · Past); Valeant Pharmaceuticals International Inc (Director · Mar 30, 2006 – Sep 28, 2010 · Past) | Director · Jul 11, 2019 – Jun 30, 2021 · Past |
| Anne Prener Other companies: Keros Therapeutics, Inc. (Director · Since at least Jun 25, 2026); Damora Therapeutics, Inc. (Director · Since at least Jan 8, 2021); Rubius Therapeutics Inc (Director · May 12, 2021 – May 12, 2022 · Past) | Director · Jun 30, 2021 – Jun 30, 2021 · Past |
| Bonnie Bassler Other companies: Cidara Therapeutics Inc (Director · Since at least Jan 22, 2021); Royalty Pharma plc (Board Member · Since at least Jun 15, 2020); Regeneron Pharmaceuticals, Inc. (Chair, Department of Molecular Biology, and Squibb Professor in Molecular Biology, Princeton University · Since at least Sep 9, 2016) | Director · Feb 27, 2019 – Jun 30, 2021 · Past |
| John Sculley Other companies: Celularity Inc. (Director · Jul 16, 2021 – Jun 14, 2023 · Past); Zeta Global Holdings Corp. (Director · Jun 9, 2021 – Jun 9, 2025 · Past); Decoy Therapeutics Inc. (Director · Jan 28, 2015 – Jun 8, 2016 · Past) | Director · Feb 27, 2019 – Feb 27, 2019 · Past |
| Joshua Brumm Other companies: Crescent Biopharma, Inc. (Chief Executive Officer · Since at least Jun 13, 2025); Dyne Therapeutics, Inc. (CEO & President, Director · Sep 16, 2020 – Mar 8, 2024 · Past); Aravive Inc (COO and CFO · Nov 12, 2015 – Oct 19, 2017 · Past) | See Remarks · Feb 27, 2019 – Mar 4, 2019 · Past |
| Richard William Scalzo Other companies: Crescent Biopharma, Inc. (Chief Financial Officer · Since at least Jun 13, 2025); Dyne Therapeutics, Inc. (SVP, Head of Finance & Admin. · Sep 16, 2020 – Mar 11, 2025 · Past) | Principal Accounting Officer · Oct 11, 2019 – Oct 11, 2019 · Past |
| Geoffrey von Maltzahn Other companies: Sana Biotechnology, Inc. (Director · Feb 3, 2021 – Feb 8, 2021 · Past) | Director · Feb 27, 2019 – Jun 30, 2021 · Past |
| Jean K Mixer Other companies: NxStage Medical Inc (Director · Feb 21, 2019 – Feb 21, 2019 · Past) | Director · Sep 30, 2019 – Jun 30, 2021 · Past |
| Jerald Korn Other companies: Epizyme Inc (Chief Operating Officer · Mar 21, 2022 – Aug 12, 2022 · Past) | COO & General Counsel · Jul 22, 2019 – Feb 28, 2022 · Past |
| Daniel L Menichella | Chief Executive Officer, Director · Oct 13, 2020 – Jan 14, 2022 · Past |
| Jonathan McIntyre | Director · Feb 27, 2019 – Feb 27, 2019 · Past |
| Vlieg Johan van Hylckama | Chief Scientific Officer · May 5, 2021 – Feb 28, 2022 · Past |